Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

      November 7, 2025
      Research & Development

      Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

      August 31, 2025
      Research & Development

      Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

      July 30, 2025
      Research & Development

      $20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

      July 11, 2025
  • Clinical
    • Clinical

      Regenxbio Reports Interim Phase 1/2 Data Showing Functional Improvement for Duchenne Gene Therapy RGX-202

      March 13, 2026
      Clinical

      Roche Shares Fall After Phase 3 Trial of Breast Cancer Drug Giredestrant Misses Primary Endpoint

      March 11, 2026
      Clinical

      Roche Reports Phase 3 Majesty Study Success for Gazyva in Primary Membranous Nephropathy

      March 1, 2026
      Clinical

      MacroGenics’ Lorigerlimab Trial Placed on Partial FDA Hold After Patient Death

      February 26, 2026
  • Commercial
    • AllBrand & Marketing
      Commercial

      Medtronic to Acquire Scientia Vascular for $550 Million to Expand Stroke Care Device Portfolio

      March 13, 2026
      Commercial

      Boehringer Terminates MASH Deal With OSE as Part of Pipeline Narrowing

      March 8, 2026
      Commercial

      Sino Biopharm’s first-in-class JAK/ROCK product has a $1.5 billion worldwide licensing agreement with Sanofi

      March 8, 2026
  • Technology
    • Technology

      Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

      July 7, 2025
      Technology

      J&J MedTech presents the first Ottava surgical robot clinical cases

      April 17, 2025
      Commercial

      Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

      October 23, 2024
      Technology

      PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

      September 26, 2024
  • Insights
    • Insights

      What Will AI Drug Discovery Look Like in 2028?

      March 14, 2026
      Insights

      What Is the Competitive Advantage of AI in Pharmaceuticals?

      March 14, 2026
      Insights

      How Will AI Change the Pharmaceutical Industry?

      March 13, 2026
      Insights

      Which Biotech Companies Are Best Positioned for AI Success?

      March 11, 2026
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
Twitter
Home Tags Lung cancer

Tag: lung cancer

Amgen’s Drug for Small Cell Lung Cancer Receives US FDA Approval
Regulatory

Amgen’s Drug for Small Cell Lung Cancer Receives US FDA Approval

Editorial Team -
May 20, 2024
0
12Page 1 of 2

Editor Picks

Spine BioPharma’s Phase 3 Trial for SB-01 in Chronic Low Back Pain Misses Primary Endpoint

August 2, 2025

Evommune Reports Phase 2a EVO301 Data in Moderate to Severe Atopic Dermatitis

February 12, 2026

Neurocrine’s Depression Drug Encounters Surprising Phase II Failure

November 13, 2025

Must Read

What Will AI Drug Discovery Look Like in 2028?

March 14, 2026

What Is the Competitive Advantage of AI in Pharmaceuticals?

March 14, 2026

How Will AI Change the Pharmaceutical Industry?

March 13, 2026

Hot Topics

  • Clinical398
  • Commercial375
  • Regulatory312
  • Research & Development102
  • Manufacturing81
  • Newsletter59
  • Technology40
  • Insights37
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
Twitter

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial